(h) Provisions and Contingent Liabilities A provision is recognised when the Company has a present obligation as a result of past event
and it is probable that an outflow of resources will be required to settle the obligation, in respect of which a reliable estimate can be
made. These are reviewed at each balance sheet date and adjusted to reflect the current best estimates.
There is an ongoing reconciliation with EESL (Energy Efficiency Services Limited) for the services rendered in the years 2016-17 and
2017-18. The company has written off all the pending receivables based on uncertainty of realisation. However, there are some pending
items with EESL, which are still under reconciliation and amount is not quantifiable which has to be mutually agreed between the
Company and EESL.
There are no other Contingent liabilities as at balance sheet date hence disclosure except this in Financial statements are not arise.
(i) Investments in subsidiaries Investment in subsidiaries are measured at cost.
(j) Property, plant and equipment : Property, plant and equipment are stated at cost comprising of purchase price and any initial directly
attributable cost of bringing the asset to its working condition for its intended use, less accumulated depreciation (other than freehold
land) and impairment loss, if any.
Depreciation is provided for property, plant and equipment on a straight line basis so as to expense the cost less residual value over
their estimated useful lives based on a technical evaluation. The estimated useful lives and residual value are reviewed at the end of each
reporting period, with the effect of any change in estimate accounted for on a prospective basis.
Depreciation is not recorded on capital work-in-progress until construction and installation is complete and the asset is ready for its
intended use.
(K) Intangible assets:
Intangible assets are recognised when it is probable that the future economic benefits that are attributable to the asset will flow to
the enterprise and the cost of the asset can be measured reliably. Intangible assets purchased are measured at cost as of the date of
acquisition, as applicable, less accumulated amortisation and accumulated impairment, if any.
Technical Knowhow: Salaries and other cost paid to resources working on new products are capitalized as intangible asset under the
head "Technical Knowhow". Management has estimated life of this product is about 10 years subject to certain improvements to the
same product/source code.
Computer Software: The Company amortizes Computer software using the straight-line method over a period of 6 years.
(l) Impairment
Financial assets (other than at fair value) The Company assesses at each date of balance sheet whether a financial asset or a group
of financial assets are impaired. Ind AS 109 requires expected credit losses to be measured through a loss allowance. For all other
financial assets, expected credit losses are measured at an amount equal to the 12 months expected credit losses or at an amount
equal to the life time expected credit losses if the credit risk on the financial asset has increased significantly since initial recognition.
(ii) Non-financial assets
Tangible and intangible assets
Property, plant and equipment and intangible assets with finite life are evaluated for recoverability whenever there is any indication
that their carrying amounts may not be recoverable. If any such indication exists, the recoverable amount (i.e. higher of the fair value
less cost to sell and the value-in-use) is determined on an individual asset basis unless the asset does not generate cash flows that
are largely independent of those from other assets. In such cases, the recoverable amount is determined for the Cash Generating
Unit (CGU) to which the asset belongs.
If the recoverable amount of an asset (or CGU) is estimated to be less than its carrying amount, the carrying amount of the asset (or
CGU) is reduced to its recoverable amount. An impairment loss is recognised in the statement of profit and loss.
(m) Employee benefits
(i) Defined contribution plans
Contributions to defined contribution plans are recognised as expense when employees have rendered services entitling them to
such benefits.
(ii) Short-term employee benefits
All employee benefits payable wholly within twelve months of rendering the service are classified as short-term employee benefits.
Benefits such as salaries, wages, Bonus, Earned Leave etc. and the expected cost of ex-gratia are recognised in the period in which
the employee renders the related service. A liability is recognised for the amount expected to be paid when there is a present
legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation can be
estimated reliably.
(n) Earnings per share
Basic earnings per share is computed by dividing profit or loss attributable to equity shareholders of the Company by the weighted
average number of equity shares outstanding during the year. Diluted earnings per equity share is computed by dividing the net profit
attributable to the equity holders of the Company by the weighted average number of equity shares considered for deriving basic
earnings per equity share and also the weighted average number of equity shares that could have been issued upon conversion of all
dilutive potential equity shares. The dilutive potential equity shares are adjusted for the proceeds receivable had the equity shares been
actually issued at fair value (i.e. the average market value of the outstanding equity shares). Dilutive potential equity shares are deemed
converted as at the beginning of the period, unless issued at a later date. Dilutive potential equity shares are determined independently
for each period presented. The number of equity shares and potentially dilutive equity shares are adjusted retrospectively for all periods
presented for any share splits and bonus shares issues including for changes effected prior to the approval of the financial statements
by the Board of Directors.
NOTE NO.23:
Details of Primary and Collateral Securities (For Liabilities referred in Note No.11 & 14)
Hypothecation of Plant and Machinery, Equipment (Movable Assets), Commercial Property and Personal guarantee of the Promoter of
the Company.
Hypothecation of Movable Assets:
1. M/s. Canara Bank, Spl Mid Corporate Branch, Hyderabad, having Hypothecation of Fixed Assets financed by them through Term Loan.
2. Charge on stock (including live stock) & Receivables and Current Assets except Cash and Bank balances of the company by M/s Canara
Bank, Spl Mid Corporate Branch for working capital limits.
3. M/s. ICICI Bank Ltd, Hyderabad, having Hypothecation of Fixed Assets financed by them through Term Loan.
4. M/s. Department of Bio Technology, New Delhi having Hypothecation of Laboratory Equipment funded by them.
Collateral Securities :
1. EMT on land admeasuring 595 Sy Yards in the name of M/s. Vivo Bio Tech Limited situated at Plot No 87, Balamrai Co operative society,
Mahendrahills, East Marredpally, Secunderabad for Loan against property given by The South Indian Bank Limited.
2. EMT on Land Square Yards 1,12,832.5 & Building Sq 1,17,197 Yards in the name of M/s. Vivo Bio Tech Limited at Sy No. 350/A, 350/C,
350/A, 351,351/B, 349/A Pregnapur Village, Gajwel Mandal, Siddipet District, Telangana for Term Loan given by M/s. Canara Bank, Spl Mid
Corporate Branch, Hyderabad for purchase of Land and Building.
3. EMI on Residential vacant land admeasuring Sy. Yards 502.32 in the name of Mr. Viswanath Kompella Situated at Plot No 36, Sy No. 3(P),
4(P), 5(P), 6 & 7, Nandagiri Hills, Shaikpet Village, Jubuileehills for Term Loan and working Capital given by M/s. Canara Bank, Spl Mid
Corporate Branch
4. EMT on Land Acre 11.00 in the name of M/s. Shri Shri Resorts Pvt Ltd at Sy No. 350/C, 351/B, 349/A, 350/A, 351 Pregnapur Village, Gajwel
Mandal, Siddipet District, Telangana for Term Loan given by M/s. ICICI Bank Ltd, Hyderabad for facility expansion .
5. EMT on Flat SFT 4716 and UDS of Sy Yards 108.01 in the name of M/s. Vivo Bio Consulting Services Pvt Ltd situated at H.No. 15-31-lhc-2A,
Flat No 1300, 13th Floor, Buena Park, Sy. No 1009, Lodha Belezza, Kukatpally Village, Medchal Malkajgiri District, Hyderbad 500072 for Loan
Against Property given by M/s. ICICI Bank Ltd, Hyderabad for business purposes.
Personal Guarantee
1. Mr. Viswanath Kompella has given personal guarantee for all loans
2. Smt K Madhavi Latha has given personal guarantee for all loans taken from M/s. Canara Bank
Corporate Guarantee, to M/s. Canara Bank, IF Branch, from following companies:
1. M/s Maxcell Phones Communications India Pvt Ltd
2. M/s Vira Systems Pvt Ltd
3. M/s Iron Age India Pvt Ltd
4. M/s Iragavarapu Constructions Pvt Ltd
5. M/s P K I Solutions Pvt Ltd
6. M/s Every wear Imports & Exports Pvt Ltd
7. M/s Vivo Bio Labs Pvt Ltd
8. M/s Surlogic Life Consultancy Pvt Ltd
NOTE NO.24:
Consumables and other than Live Stock are valued at cost or realizable value whichever is less. Since company is engaged in breeding and
trading activity of Rodents and cost of rodent stock is difficult to ascertain hence rodents in stock valued at realizable Value. With regards
to other stock like rodent Feed, bedding material, Transit cages, Stores and Spares are valued at cost or realizable value whichever is lower.
NOTE NO.27:
The Company has been awarded soft loan given by SBIRI (Small Business Innovation Research Initiative), Department of Bio Technology,
towards the project - "Production of recombinant eventide (Incretin mimetic like GLP-1) (Phase II) a new generation cure for Diabetes" given
specifically for the R&D work being carried out by company's biologic division operating from the facility located at Pothaipally Village,
Hakimpet recognized by DSIR (Department of Scientific and Industrial Research) as in-house R&D unit vide approval F.No. TU/IV-RD/2740/2010
A separate mortgage is created for the whole of movable and immovable properties acquired from the loan sanctioned by the DBT under
the SBIRI scheme including its movable plant and machinery, machinery spares, tools and accessories and other movables both present and
future (except book debts).
NOTE NO.28: RELATED PARTY TRANSACTIONS
All related party transactions that were entered into during the financial year were on arm's length basis and were in the ordinary course
of business. There are no materially significant related party transactions made by the Company with Promoters, Directors, Key Managerial
Personnel or other designated persons which may have a potential conflict with the interest of Company at large.
Related Party Disclosures
a) Subsidiary Companies:
1. Vivo Bio Labs Private Limited
2. Vivo Bio Discovery Services Private Limited
3. Surlogic Life Consultancy Services Private Limited
4. Vivo bio Consulting Services Private Limited
b) Directors:
1. M. Kalyan Ram
2. Alangudi Sankaranarayanan
3. Sri Kalyan Kompella
4. Shivanand Nayak Karopadi
5. Kunda Kalpana
6. Shyam Sunder Tipparaju
NOTE NO.30:
Foreign Currency Outflow during the year of H Nil Lakhs (Previous Year - H 102.83 Lakhs).
NOTE NO.31:
Foreign Currency Inflow during the year is H 633.36 Lakhs (Previous Year - H 496.07 Lakhs.)
NOTE NO.32:
There are no dues to MSME Units outstanding for more than 45 days.
NOTE 33: ADDITIONAL REGULATORY INFORMATION
i. The Company is in possession of immovable property and title deeds are held in the Name of the company.
ii. The Company has not revalued any of its Property, Plant and Equipment during the year.
iii. The Company has not granted any loans or advances in the nature of loans to directors, KMPs
iv. There are no proceedings initiated or pending against the company for holding any Benami property under the Benami Transactions
(Prohibition) Act, 1988 (45 of 1988) and rules made there under.
v. The Company has borrowings from banks or financial institutions on the basis of security of current assets and the quarterly returns or
statements filed by the company with such banks or financial institutions are in agreement with the books of account of the Company.
vi. The Company is not declared as willful defaulter by any bank or financial Institution or other lenders.
vii. The Company did not have any transactions with Companies struck off under Section 248 of Companies Act, 2013 or Section 560 of
Companies Act, 1956 considering the information available with the Company.
NOTE: 34
The Company does not have any transactions which are not recorded in the books of accounts that has been surrendered or disclosed as
income in the tax assessments under the Income Tax Act, 1961 during the year.
NOTE: 35:
The Company has not traded or invested in Crypto currency or Virtual Currency during the financial year.
NOTE: 36:
There are no significant events that occurred after the balance sheet date.
NOTE: 37:
The Company has not declared any dividend during the year.
NOTE: 38:
In the opinion of the management, the assets as shown in the financial Statements have a value on realization in the ordinary course of
business of at least equal to the amount at which they are stated in the balance sheet.
i) Debt-Equity Ratio: Variance -48.86% due to repayment of Term Loans and issue of capital/conversion of Share warrants.
ii) Return on Equity Ratio : Variance 140.58% : due to increase of Profit during the year on account of sale of Land.
iii) Net Capital Turnover Ratio : Variance -26.37% due to repayment of unsecured short term borrowings.
iv) Net Profit Ratio : Variance 188.63% due to increase of Profit during the year on account of sale of Land.
NOTE NO.40:
Previous year's numbers have been regrouped, rearranged, re casted, wherever necessary to conform to Current Year Classification
As per our Report of Even Date For and on behalf of the Board of Directors of
FOR P.Murali & Co. Vivo Bio Tech Limited
Chartered Accountants
Firm Registration No.007257S
M.V. Joshi M.Kalyan Ram K.Sri Kalyan
Partner Whole Time Director Whole Time Director & CFO
M. No. 024784 DIN: 02012580 DIN: 03137506
Vaishnvi Kiran Ayinampudi
Place : Hyderabad Company Secretary
Date: 19/05/2025 M.No.A60906
|